NovaBridge Biosciences APIC, Share-based Payment Arrangement, Increase for Cost Recognition
NovaBridge Biosciences (NBP) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $5.97 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-04-07
- NovaBridge Biosciences apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2020-12-31 was 100.89M CNY, a 1008780.00% increase year-over-year.
- NovaBridge Biosciences apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2019-12-31 was 10.00K CNY.
CNY
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2023-12-31 | 193.00M CNY 20-F · filed 2024-04-30 | |||
| 2022-12-31 | 357.15M CNY 20-F · filed 2024-04-30 | |||
| 2022-06-30 | 196.94M CNY 6-K · filed 2022-11-10 | |||
| 2021-12-31 | 608.61M CNY 20-F · filed 2024-04-30 | |||
| 2021-06-30 | 334.72M CNY 6-K · filed 2022-11-10 | |||
| 2020-12-31 | 100.89M CNY derived: 20-F 12 month − 6-K 9 month · filed 2023-05-01 | 402.41M CNY 20-F · filed 2023-05-01 | ||
| 2020-09-30 | 301.52M CNY 6-K · filed 2021-02-05 | |||
| 2019-12-31 | 10.00K CNY derived: 20-F 12 month − 6-K 9 month · filed 2022-04-29 | 366.89M CNY 20-F · filed 2022-04-29 | ||
| 2019-09-30 | 366.88M CNY 6-K · filed 2021-02-05 | |||
| 2018-12-31 | 3.52M CNY 20-F · filed 2021-04-28 | |||
| 2017-12-31 | 7.04M CNY 20-F · filed 2020-04-29 |
USD
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.96M derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | $5.40M derived: sum of 2 quarters · filed 2026-04-07 | $5.97M 20-F · filed 2026-04-07 | |
| 2025-09-30 | $1.45M derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | $2.02M 6-K · filed 2025-12-18 | ||
| 2025-06-30 | $572.00K 6-K · filed 2025-10-06 | |||
| 2024-12-31 | $825.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | $1.14M derived: sum of 2 quarters · filed 2026-04-07 | -$13.51M 20-F · filed 2026-04-07 | |
| 2024-09-30 | $316.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | -$14.34M 6-K · filed 2025-12-18 | ||
| 2024-06-30 | -$14.65M 6-K · filed 2025-10-06 | |||
| 2023-12-31 | $27.35M 20-F · filed 2026-04-07 | |||
| 2022-12-31 | $52.85M 20-F · filed 2025-04-03 |